Bionano Genomics (BNGO) Market Capitalization (2018 - 2026)

Bionano Genomics has disclosed Market Capitalization across 9 years of filings, most recently posting $13.3 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 3.79% year-over-year to $13.3 million; the TTM figure through Jun 2026 stood at $13.3 million (up 3.79% YoY), while the FY2025 annual figure was $8.3 million, down 62.33% from the prior year.
• Market Capitalization came in at $13.3 million for Q2 2026 at Bionano Genomics, up from $13.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $44.8 billion in Q1 2022 to a low of $8.3 million in Q4 2025.
• Average Market Capitalization over 5 years is $10.0 billion, with a median of $3.4 billion recorded in 2024.
• Year-over-year, Market Capitalization tumbled 99.77% in 2025 and surged 52.47% in 2026.
• Over 5 years, Market Capitalization stood at $26.0 billion in 2022, then tumbled by 85.12% to $3.9 billion in 2023, then tumbled by 99.43% to $22.1 million in 2024, then sank by 62.33% to $8.3 million in 2025, then soared by 59.75% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $13.3 million in Q2 2026, $13.2 million in Q1 2026, and $8.3 million in Q4 2025.